TMPRSS2: ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Oncogene Proteins, Fusion
  • Prostatic Intraepithelial Neoplasia
  • Prostatic Neoplasms
  • Toremifene

abstract

  • This study underscores the necessity of more stringent follow-up for men with HGPIN that is also positive for ERG overexpression. Clinicians should consider molecular characterization of HGPIN as a means to improve risk stratification.

publication date

  • January 20, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3887478

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.49.8386

PubMed ID

  • 24297949

Additional Document Info

start page

  • 206

end page

  • 11

volume

  • 32

number

  • 3